Investigation Overview
January 31, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Meridian Bioscience, Inc. (NASDAQ:VIVO) shares over potential securities laws violations by Meridian Bioscience, Inc. and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchase...
You must register (for free) or login to view the entire investigation.